JP2017519730A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017519730A5 JP2017519730A5 JP2016567543A JP2016567543A JP2017519730A5 JP 2017519730 A5 JP2017519730 A5 JP 2017519730A5 JP 2016567543 A JP2016567543 A JP 2016567543A JP 2016567543 A JP2016567543 A JP 2016567543A JP 2017519730 A5 JP2017519730 A5 JP 2017519730A5
- Authority
- JP
- Japan
- Prior art keywords
- infection
- composition
- composition according
- bacterium
- probiotic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 15
- 241000894006 Bacteria Species 0.000 claims 12
- 239000006041 probiotic Substances 0.000 claims 9
- 230000000529 probiotic effect Effects 0.000 claims 9
- 235000018291 probiotics Nutrition 0.000 claims 9
- 208000015181 infectious disease Diseases 0.000 claims 6
- 208000035143 Bacterial infection Diseases 0.000 claims 3
- 241000186660 Lactobacillus Species 0.000 claims 3
- 230000001580 bacterial effect Effects 0.000 claims 3
- 208000022362 bacterial infectious disease Diseases 0.000 claims 3
- 239000012634 fragment Substances 0.000 claims 3
- 230000002101 lytic effect Effects 0.000 claims 3
- 239000000126 substance Substances 0.000 claims 3
- 206010041925 Staphylococcal infections Diseases 0.000 claims 2
- 241000191967 Staphylococcus aureus Species 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 229940039696 lactobacillus Drugs 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 230000000699 topical effect Effects 0.000 claims 2
- 239000012049 topical pharmaceutical composition Substances 0.000 claims 2
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims 1
- 241000191940 Staphylococcus Species 0.000 claims 1
- 230000000845 anti-microbial effect Effects 0.000 claims 1
- 239000004599 antimicrobial Substances 0.000 claims 1
- 239000006071 cream Substances 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000028327 secretion Effects 0.000 claims 1
- 206010040872 skin infection Diseases 0.000 claims 1
- 239000007921 spray Substances 0.000 claims 1
- 208000015339 staphylococcus aureus infection Diseases 0.000 claims 1
- 238000011200 topical administration Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1409541.8A GB201409541D0 (en) | 2014-05-29 | 2014-05-29 | Probiotic Bacteria |
| GB1409541.8 | 2014-05-29 | ||
| PCT/GB2015/051529 WO2015181534A1 (en) | 2014-05-29 | 2015-05-26 | Anti-bacterial lysate of probiotic bacteria |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017519730A JP2017519730A (ja) | 2017-07-20 |
| JP2017519730A5 true JP2017519730A5 (enExample) | 2018-07-12 |
| JP6741595B2 JP6741595B2 (ja) | 2020-08-19 |
Family
ID=51214406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016567543A Active JP6741595B2 (ja) | 2014-05-29 | 2015-05-26 | プロバイオティック細菌の抗菌性溶解物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10702562B2 (enExample) |
| EP (1) | EP3148558B1 (enExample) |
| JP (1) | JP6741595B2 (enExample) |
| CN (1) | CN106794205B (enExample) |
| AU (1) | AU2015265698B2 (enExample) |
| CA (1) | CA2950510C (enExample) |
| ES (1) | ES2842215T3 (enExample) |
| GB (1) | GB201409541D0 (enExample) |
| WO (1) | WO2015181534A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201409541D0 (en) | 2014-05-29 | 2014-07-16 | Univ Manchester | Probiotic Bacteria |
| GB2544481B (en) * | 2015-11-16 | 2019-12-11 | Century International Enterprises Ltd | A wearable article and a method for producing a wearable article |
| GB201608762D0 (en) | 2016-05-18 | 2016-06-29 | Skinbiotix Ltd | Compositions and uses thereof |
| CL2017001273A1 (es) * | 2017-05-17 | 2018-03-16 | Univ San Sebastian | Aerosol orofaríngeo compuesto por un hidrolizado derivado de un probiótico que tiene impacto en la inmunidad del tracto genitourinario, método de obtención del hidrolizado, composiciones farmacéuticas que lo contienen y uso de las mismas. |
| GB201807576D0 (en) | 2018-05-09 | 2018-06-20 | Skinbiotherapeutics Plc | Compositions and uses thereof |
| CN112957404A (zh) * | 2021-02-08 | 2021-06-15 | 广东广汇农牧有限公司 | 一种用于母猪阴道护理的环保型清洗液组合物及其制备方法 |
| WO2022195109A1 (en) * | 2021-03-19 | 2022-09-22 | Eligo Bioscience | Therapeutic use of engineered postbiotics comprising bacteriocins and/or endolysins |
| WO2022195108A2 (en) * | 2021-03-19 | 2022-09-22 | Eligo Bioscience | Cosmetic use of engineered postbiotics comprising bacteriocins and/or endolysins |
| CN113046268B (zh) * | 2021-03-24 | 2023-01-31 | 华熙生物科技股份有限公司 | 鼠李糖乳杆菌、调节皮肤微生态的发酵溶胞物、制法及其应用 |
| CN114717131B (zh) * | 2021-09-07 | 2023-05-26 | 青岛蔚蓝生物股份有限公司 | 一株对皮肤损伤具有保护作用的鼠李糖乳杆菌及其应用 |
| WO2025023853A1 (en) | 2023-07-27 | 2025-01-30 | Universitatea "Dunărea De Jos" Din Galaţi | Obtaining processes for some metabiotic ingredients with bioactive properties based on bovine colostrum and potentially probiotic lactic acid bacteria belonging to lactiplantibacillus spp |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008503563A (ja) * | 2004-06-23 | 2008-02-07 | ロレアル | 敏感及び／又は乾燥肌の予防及び／又は処置に有用な方法及び組成物 |
| US20110039765A1 (en) * | 2008-04-17 | 2011-02-17 | Connor Ruth I | Bioactive Molecules Produced by Probiotic Bacteria |
| WO2009155711A1 (en) | 2008-06-27 | 2009-12-30 | University Of Guelph | Analysis of lactobacillus acidophilus la-5 signal interference molecules |
| PL2704704T3 (pl) * | 2011-05-03 | 2019-04-30 | Dupont Nutrition Biosci Aps | Bakterie probiotyczne do miejscowego leczenia zaburzeń skóry |
| GB201206599D0 (en) * | 2012-04-13 | 2012-05-30 | Univ Manchester | Probiotic bacteria |
| GB201409541D0 (en) | 2014-05-29 | 2014-07-16 | Univ Manchester | Probiotic Bacteria |
-
2014
- 2014-05-29 GB GBGB1409541.8A patent/GB201409541D0/en not_active Ceased
-
2015
- 2015-05-26 WO PCT/GB2015/051529 patent/WO2015181534A1/en not_active Ceased
- 2015-05-26 EP EP15727045.5A patent/EP3148558B1/en active Active
- 2015-05-26 CN CN201580028700.4A patent/CN106794205B/zh active Active
- 2015-05-26 CA CA2950510A patent/CA2950510C/en active Active
- 2015-05-26 JP JP2016567543A patent/JP6741595B2/ja active Active
- 2015-05-26 ES ES15727045T patent/ES2842215T3/es active Active
- 2015-05-26 US US15/314,897 patent/US10702562B2/en active Active
- 2015-05-26 AU AU2015265698A patent/AU2015265698B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017519730A5 (enExample) | ||
| WO2017049233A3 (en) | Lysin polypeptides active against gram-negative bacteria | |
| PH12019500360A1 (en) | Antibiotic compounds | |
| WO2017017631A3 (en) | Antibacterial therapeutics and prophylactics | |
| WO2018208985A3 (en) | Antibacterial compounds | |
| NZ630117A (en) | Bacterial strains having antimicrobial activity and biocontrol compositions comprising the same | |
| WO2010036876A3 (en) | Compositions and methods for characterizing and restoring gastrointestinal, skin, and nasal microbiota | |
| WO2018208987A3 (en) | Antibacterial compounds | |
| WO2016070151A8 (en) | Methods and compositions relating to microbial treatment and diagnosis of disorders | |
| BR112018068593A2 (pt) | composições tópicas não aquosas que compreendem uma salicilanilida halogenada | |
| RU2014145534A (ru) | Пробиотические бактерии | |
| MY172685A (en) | A lactobacillus crispatus and application thereof | |
| Yang et al. | Farrerol regulates antimicrobial peptide expression and reduces Staphylococcus aureus internalization into bovine mammary epithelial cells | |
| EP3787668C0 (en) | PROBIOTIC BACTERIAL STRAINS THAT PRODUCE ANTIMICROBIAL PROTEINS AND COMPOSITIONS THEREOF FOR THE TREATMENT OF A CLOSTRIDIUM DIFFICILE INFECTION | |
| WO2020061375A8 (en) | Antibacterial compounds | |
| Khalfallah et al. | A new approach to harness probiotics against common bacterial skin pathogens: Towards living antimicrobials | |
| WO2015112980A3 (en) | Dermaseptin-type and piscidin-type antimicrobial peptides | |
| JP2012513467A5 (enExample) | ||
| ZA202002093B (en) | Antibacterial compounds | |
| Islam et al. | Evaluation of antibacterial activities of latex of Caricaceae (Carica papaya L.) | |
| BR112017014225A2 (pt) | cultura biologicamente pura de lactobacillus reuteri, cepas lactobacillus reuteri, composição de uso de uma ou mais cepas de bactérias do ácido láctico, e da composição, e, método para administração tópica de cepas de bactérias do ácido láctico. | |
| BR112021015638A2 (pt) | Métodos, composições contendo bactéria produtora de bacileno ou preparações das mesmas | |
| JP2015522040A5 (enExample) | ||
| MX2019006086A (es) | Uso de una composicion bacteriana para tratar infecciones en las patas de ungulados. | |
| TR201808116T1 (tr) | İnsanlarda ve hayvanlarda kullanilmak üzere yeni̇ probi̇yoti̇k başlatici kültür |